Detalles de la búsqueda
1.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol
; 13(3): 239-46, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22285168
2.
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.
J Transl Med
; 9: 163, 2011 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21951562
3.
PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance.
Cancer Invest
; 26(10): 1044-51, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18798071
4.
The impact of participatory teaching methods on medical students' perception of their abilities and knowledge of epidemiology and statistics.
PLoS One
; 13(8): e0202769, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30133528
5.
Low RAP80 mRNA expression correlates with shorter survival in sporadic high-grade serous ovarian carcinoma.
Int J Biol Markers
; 32(1): e90-e95, 2017 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443420
6.
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.
J Clin Oncol
; 23(36): 9105-12, 2005 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16361617
7.
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Clin Cancer Res
; 11(16): 5878-85, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16115929
8.
Methylation patterns and chemosensitivity in NSCLC.
Adv Exp Med Biol
; 587: 195-209, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17163167
9.
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
Clin Cancer Res
; 10(12 Pt 2): 4215s-4219s, 2004 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15217961
10.
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
Clin Lung Cancer
; 5(6): 360-5, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15217535
11.
Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.
Clin Cancer Res
; 20(17): 4647-59, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24696321
12.
Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC).
Transl Lung Cancer Res
; 2(3): 180-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25806231
13.
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.
Lung Cancer
; 72(1): 84-91, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705357
14.
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.
Clin Cancer Res
; 17(5): 1160-8, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21233402
15.
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.
Lung Cancer
; 68(3): 491-7, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19733931
16.
The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.
PLoS One
; 5(3): e9499, 2010 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20209131
17.
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
PLoS One
; 3(11): e3695, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19002265
18.
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.
J Clin Oncol
; 25(19): 2747-54, 2007 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17602080
19.
Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.
J Clin Oncol
; 25(30): 4736-42, 2007 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17947721
Resultados
1 -
19
de 19
1
Próxima >
>>